The U.S. Centers for Disease Control and Prevention (CDC) prepared to alert state and local officials about a potential connection between heart inflammation and COVID-19 vaccines but ultimately did not send the message, according to a document obtained by The Epoch Times. The document reveals that all four COVID-19 vaccines available in the United States can cause myocarditis, a type of heart inflammation. The first cases were reported shortly after the vaccines became available in late 2020.
The CDC typically sends alerts through a system called the Health Alert Network (HAN), which conveys vital health information to public health officials and doctors across the nation. In May 2021, CDC officials drafted an alert on myocarditis and the two most widely used COVID-19 shots, Pfizer-BioNTech and Moderna vaccines. However, the draft alert was never sent. Instead, the agency chose to issue a document called “clinical considerations,” which acknowledged an increased number of reported myocarditis cases after mRNA vaccination but still recommended vaccination for most people above the age of 11.
The decision to change the alert to a statement was made after a call with CDC partners, as revealed in other emails. This raises questions about why an alert was issued for blood clotting and low platelet levels after the Johnson & Johnson vaccine but not for myocarditis post-mRNA vaccination. The CDC has been criticized for its pattern of behavior in censoring information that challenges the narrative that COVID-19 vaccines are safe and effective.
The CDC's failure to send the alert on myocarditis raises concerns about a double standard in vaccine safety communication. The agency has previously issued alerts on various COVID-19-related topics, including testing, travel, and a rare disease called MIS-C linked to COVID-19. However, when it came to myocarditis post-mRNA vaccination, the alert was not sent despite hundreds of reported cases and even deaths.
Experts, such as Dr. Tracy Hoeg, an epidemiologist, argue that CDC officials involved in the draft should testify before Congress to explain why the alert was not released. Dr. Hoeg believes it is crucial to determine who made the decision and why, especially considering the available data and reports from other countries.
The U.S. House of Representatives Select Subcommittee on the Coronavirus Pandemic, which is investigating the U.S. response to the pandemic, declined to comment on the matter.
This revelation adds to the growing concerns about transparency and communication regarding vaccine safety. The CDC and other agencies have repeatedly failed to disclose information that undermines their promotion of COVID-19 vaccines, including the number of cases among the vaccinated.
